Martin Tolar of Alzheon receives the “Czech Laurels Award” from the Chamber of Commerce of the Czech Republic
Breaking News in the Field of Alzheimer’s: Alzheon Announces First Patient Dosed in Phase 3 TrialGeneration Bold
Investor interest in Alzheimer’s ‘changed on the dime’ following FDA’s decision on Biogen’s aducanumabFIERCE Biotech
“Alzheimer’s is open for business:” Controversial FDA approval could pave the way for future drugsTechCrunch
